The Digital PCR Market growth is driven mainly by the rising incidence of target infectious diseases and genetic disorders; technological advancements in PCR technologies; increasing investments, funds, and grants; increasing use of biomarker profiling for disease diagnostics; and successful completion of the Human Genome Project.

According to research report the global Digital PCR Market size is projected to reach USD 7.6 billion by 2025 from USD 4.9 billion in 2020, at a CAGR of 9.0%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=174151204

The market is segmented by Product (Instruments, Reagents Consumables, Software Services), Application (Clinical, Research, Forensic), End User (Hospitals Diagnostic Centers, Pharma Biotech, CROs) and Region.

• Based on product, the qPCR  market is segmented into reagents and consuables; instruments; and software and services. The reagents and consumables segment is expected to witness the highest growth during the forecast period. Factors such as the expanding applications of qPCR (owing to its technological benefits over traditional PCR, such as real-time analysis and reduced analysis time), growing private-public funding for life science research, and the rising number of probe-based multiplex genetic analysis procedures (that require the analysis of low-volume gene samples) are expected to drive the growth of the qPCR reagents and consumables market.

• Based on the type, the dPCR market is segmented into reagents and consuables; instruments; and software and services. The reagents and consumables segment accounted for the largest share of the global dPCR market in 2019. This segment includes specific reagents (such as master mixes, assay kits, and enzymes) and consumables (such as reaction tubes, needles, and vials) used during dPCR procedures. Generally, dPCR reagents consist of a super mix or a master mix that contains the buffer, DNA polymerase, dNTPs, and dsDNA-binding dyes.

• North America accounted for the largest share of the global dPCR and qPCR market, followed by North America. The large share of the North American market is attributed to the increased adoption of innovative and novel genomic analysis products (including advanced qPCR and dPCR products), availability of R&D funding for genomic research (coupled with the robust research infrastructure in the region), expanding use of PCR techniques in clinical diagnostics & forensics, and early commercialization of qPCR/dPCR products compared to other regions.

The prominent players operating in the Digital PCR Market are Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc. (US), and F. Hoffmann-La Roche, Ltd. (Switzerland).

Request For Free Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=174151204

This market research study involved the extensive use of secondary sources, directories, and databases to identify and collect information useful for this technical, market-oriented, and financial study of the global dPCR and qPCR market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, to obtain and verify critical qualitative and quantitative information and to assess market prospects. The size of the Digital PCR Market was estimated through various secondary research approaches and triangulated with inputs from primary research to arrive at the final market size.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]